Navigation Links
Vandetanib shows clinical benefit when combined with docetaxel for lung cancer
Date:6/1/2009

9,390 will likely die from the disease.

The ZODIAC, (Zactima in cOmbination with Docetaxel In non-smAll cell lung Cancer) study enrolled 1,391 patients with non-small cell lung cancer from 198 centers between May 2006 and April 2008; all had received chemotherapy previously. Participants were randomized to receive either docetaxel and placebo, or docetaxel and vandetanib. The median follow-up was 12.8 months and the study's primary endpoint was progression-free survival.

Patients in the combination arm had a 21 percent reduction in disease progression, compared to those who received docetaxel alone (hazard ratio, .79), and their median progression-free survival was 17.3 weeks. In contrast, the median progression-free survival in the control arm was 14 weeks. While it trended positive, however, there was no statistical difference in overall survival in the two groups. There was a statistically significant improvement in the time to worsening of symptoms (hazard ratio, .77).

"Obviously, our ultimate goal is to always improve survival for our patients, however the improved time to progression with less of a number of significant effects is important," said Herbst. "This is certainly a drug, where, if we could identify molecular parameters that predict response, we could some day take a group that's receiving docetaxel and vandetanib and see them do even better. We're not there yet, but hopefully this study will serve as the foundation for the merger of personalization and discovery with the now-proven safety and efficacy."

In terms of side effects, patients who received vandetanib experienced more diarrhea, rash and neutropenia. However, they experienced less of the significant side effects - nausea, vomiting, and anemia - than those who received docetaxel alone. The lack of significant side effects is quite striking, said Herbst, because other agents that target VEGF are associated with increased toxicity, including pulmonary blee
'/>"/>

Contact: Laura Sussman
lsussman@mdanderson.org
832-264-8893
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Enrollment completed in 2 pivotal phase III studies of the investigational cancer drug vandetanib
2. Vaccine shows therapeutic promise against advanced melanoma
3. Study shows gay couples want legal rights, regardless of marriage
4. Immune-Based Lymphoma Treatment Shows Promise
5. Avastin Shows No Benefit Against Early Stage Colon Cancer
6. Study shows drug combination improves outcome for advanced non-small cell lung cancer
7. Tool Shows Promise for Measuring Productivity of Mid-Level Oncology Providers
8. New Study Shows Probiotics Linked to Metabolism
9. Small molecule inhibitor shows promise in trastuzumab-resistant metastatic breast cancer
10. Cottonseed-based drug shows promise in treating severe brain cancer
11. Dementia drugs may put some patients at risk, Queens study shows
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Vandetanib shows clinical benefit when combined with docetaxel for lung cancer
(Date:6/30/2015)... , ... June 30, 2015 , ... ... call and communications software, Notify™, for the senior care sector. As an innovator ... helping senior housing facilities to become more efficient and offer residents better care. ...
(Date:6/30/2015)... ... June 30, 2015 , ... Nuretix ... with Knockout Zone Miami (KO Zone), a state-of-the-art training facility ... CrossFit Coach, Diego de Vera. The partnership will provide KO Zone clients and ...
(Date:6/30/2015)... ... ... The campaign aims to make digestive wellness a more conversational topic, educating on the ... Americans face and inspiring readers to be more proactive by providing them the tools ... “Digestive Wellness” is distributed within USA Today in Los Angeles, New York, Chicago, Miami ...
(Date:6/30/2015)... Soledad, CA (PRWEB) , ... June 30, 2015 , ... ... off the florets once in the kitchen, and discard the stalks before cooking. Throwing ... parts actually can be eaten and are quite delicious. It just takes a little ...
(Date:6/30/2015)... ... 2015 , ... When it comes to volunteering abroad, not many people end ... be too high. However, there are affordable programs to be had such as those ... cost. One such volunteer named Uzma Aishah, a student at the International Medical University ...
Breaking Medicine News(10 mins):Health News:Eldermark Leap-Frogs other Nurse Call and Communication Systems with Notify 2Health News:Eldermark Leap-Frogs other Nurse Call and Communication Systems with Notify 3Health News:Top Sports Nutrition Brand, Liporidex, Announces Partnership With Leading Boxing, CrossFit and MMA Gym, Knockout Zone of Miami 2Health News:Top Sports Nutrition Brand, Liporidex, Announces Partnership With Leading Boxing, CrossFit and MMA Gym, Knockout Zone of Miami 3Health News:Mediaplanet’s “Digestive Wellness” Campaign Urges You To Listen to What Your Stomach Is Telling You and Talk About It 2Health News:Whole Vegetable Cooking for Home Cooks: Josie's Organics Encourages Using All Parts of Vegetables – from Root to Stalk – Every Day 2Health News:Whole Vegetable Cooking for Home Cooks: Josie's Organics Encourages Using All Parts of Vegetables – from Root to Stalk – Every Day 3Health News:Whole Vegetable Cooking for Home Cooks: Josie's Organics Encourages Using All Parts of Vegetables – from Root to Stalk – Every Day 4Health News:Volunteers Transform Themselves and Their Resumes with Medical Volunteer Placements Abroad 2Health News:Volunteers Transform Themselves and Their Resumes with Medical Volunteer Placements Abroad 3
... Davis team of cardiovascular specialists has demonstrated the effectiveness of ... to repair aortas that are torn as the result of ... Association for Thoracic Surgery Aortic Symposium 2010, which takes place ... looking for ways to reduce the impact of surgical treatment ...
... the dawn of a new age in genomics, researcher says ... a Stanford University professor of bioengineering, now has a very ... was the focus of the first completely mapped genome of ... The scan was conducted by a team of Stanford researchers ...
... transplant recipients are known to have a higher risk of ... to take immunosuppressive drugs to prevent organ rejection. Results published ... medication appears to increase this cancer risk. Evaluating data ... trends among 481 patients over 20 years - providing the ...
... Can medicine, science and faith ... proper evidences that reveal the existence of our souls, Heaven and God? If so, where ... to Heaven and returned to tell us about it in this day and age? , ... (PRWEB) April 30, 2010 -- Many profound questions ...
... say the measure makes the wrong changes, poll finds ... after President Barack Obama signed the historic health-reform bill ... many people still unsure how it will affect them, ... opponents of the reform package are roughly equally divided, ...
... SUPERNANNY New York Open Casting Call for ... Saturday May 15th from 2 to 6PM. Lucie B,s Jump N Fun is the First and ... Sip on Seltzer, Have Fun...and Maybe make the cut for SUPERNANNY. , ... Baldwin, New York (PRWEB) April 30, 2010 -- Lucie B,s Jump N Fun has ...
Cached Medicine News:Health News:Research team documents benefits of endovascular stent repair for traumatic aortic injury 2Health News:Genome Scan Gives Man Insight Into Future Health Risks 2Health News:Genome Scan Gives Man Insight Into Future Health Risks 3Health News:Cancer risk for kidney transplant 2Health News:Secrets to Life, the Shroud of Turin, and Heaven's Mysteries Revealed 2Health News:Secrets to Life, the Shroud of Turin, and Heaven's Mysteries Revealed 3Health News:Americans Still Split Over New Health Reform Law 2Health News:Americans Still Split Over New Health Reform Law 3Health News:Americans Still Split Over New Health Reform Law 4Health News:Supernanny New York Casting Call @ Lucie B's Jump N Fun- NY's 1st Jump Rope Gym For Kids in Baldwin 2
(Date:6/30/2015)... , June 30, 2015  Inari Medical, Inc. announced ... B venture capital financing. The financing was led by ... Versant Ventures and US Venture Partners.  The round also ... "We are very pleased to complete this financing ... Bill Hoffman , who joined in February 2015 ...
(Date:6/30/2015)... , June 30, 2015  Avanir Pharmaceuticals, Inc. ... study showing that treatment with NUEDEXTA ® ... symptoms of pseudobulbar affect (PBA) in patients with ... a distressing condition characterized by sudden and uncontrollable ... neurologic diseases or brain injury. PRISM II is ...
(Date:6/30/2015)... NEW YORK , June 30, 2015 /PRNewswire/ – ... ARYC) had an agreement to supply custom Arrayit blood ... private human DNA vault on earth. Vivos offers an ... provide virtually every man, woman and child on Earth, ... store their DNA. Arrayit blood cards allow the rapid ...
Breaking Medicine Technology:Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 2Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 4Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 5Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 6Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 7Small Cap IR - Empowering the Age of Genetic Enlightenment 2
... Sigma-Aldrich Corporation (NASDAQ: SIAL ) today announced ... ( www.safcglobal.com ), is introducing a novel CHOZN® GS-/- ... line. Designed for use in the production of biopharmaceuticals, ... commercially available glutamine synthetase (GS) knockout CHO cell line ...
...  The Eli Lilly and Company Foundation has committed US $30 ... in its fight against multidrug-resistant tuberculosis – a disease that ... each year. The announcement was made ahead of the opening ... Lille, France, later this week. Eli Lilly ...
Cached Medicine Technology:SAFC Introduces the First Commercially Available Novel CHOZN® GS Knockout CHO Cell Line 2SAFC Introduces the First Commercially Available Novel CHOZN® GS Knockout CHO Cell Line 3SAFC Introduces the First Commercially Available Novel CHOZN® GS Knockout CHO Cell Line 4Lilly Foundation Commits US $30 Million to The Lilly MDR-TB Partnership 2Lilly Foundation Commits US $30 Million to The Lilly MDR-TB Partnership 3Lilly Foundation Commits US $30 Million to The Lilly MDR-TB Partnership 4Lilly Foundation Commits US $30 Million to The Lilly MDR-TB Partnership 5
Taper with blunt tip. Stainless steel. Round knurled handle with polished finish. Taper : Medium 23 mm. Overall length: 3.9 inches....
Taper with blunt tip. Stainless steel. Round knurled handle with polished finish. Taper : Short 19 mm. Overall length: 3.9 inches....
Size 2 dilator. Stainless steel. Round knurled handle with polished finish. Overall length: 4 inches....
Double ended dilator probes with gentle curve. Stainless steel. Round knurled handle with polished finish. Overall length: 5.3 inches....
Medicine Products: